You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
|
|---|---|
| Published in |
npj Vaccines, May 2023
|
| DOI | 10.1038/s41541-023-00662-6 |
| Pubmed ID | |
| Authors |
Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E. Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz-Stern, Yolanda López-Vidal, Alejandro E. Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino López-Macías, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard |
X Demographics
The data shown below were collected from the profiles of 356 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 141 | 40% |
| United States | 3 | <1% |
| Canada | 2 | <1% |
| Malta | 1 | <1% |
| Germany | 1 | <1% |
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Korea, Democratic People's Republic of | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 203 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 332 | 93% |
| Scientists | 15 | 4% |
| Practitioners (doctors, other healthcare professionals) | 6 | 2% |
| Science communicators (journalists, bloggers, editors) | 3 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 19 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 3 | 16% |
| Researcher | 3 | 16% |
| Professor | 2 | 11% |
| Student > Master | 2 | 11% |
| Lecturer | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 7 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 4 | 21% |
| Immunology and Microbiology | 4 | 21% |
| Agricultural and Biological Sciences | 2 | 11% |
| Nursing and Health Professions | 2 | 11% |
| Unknown | 7 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 305. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2024.
All research outputs
#114,602
of 26,017,215 outputs
Outputs from npj Vaccines
#25
of 834 outputs
Outputs of similar age
#2,862
of 403,493 outputs
Outputs of similar age from npj Vaccines
#2
of 46 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 834 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,493 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.